Perspective Therapeutics (CATX) EBT Margin Growth (3y) (2013 - 2023)
Perspective Therapeutics (CATX) EBT Margin Growth (3y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 329.00 |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 19,536.00 |
| Sep 30, 2023 | -44,405.00 |
| Jun 30, 2023 | -68,827.00 |
| Mar 31, 2023 | -57,512.00 |
| Sep 30, 2022 | -20,168.00 |
| Jun 30, 2022 | -2,604.00 |
| Mar 31, 2022 | 1,239.00 |
| Dec 31, 2021 | 1,730.00 |
| Sep 30, 2021 | 906.00 |
| Jun 30, 2021 | 19,677.00 |
| Mar 31, 2021 | 5,603.00 |
| Dec 31, 2020 | 5,845.00 |
| Sep 30, 2020 | 9,776.00 |
| Jun 30, 2020 | 8,181.00 |
| Mar 31, 2020 | 8,716.00 |
| Dec 31, 2019 | 10,039.00 |
| Sep 30, 2019 | 10,767.00 |
| Jun 30, 2019 | 5,041.00 |
| Mar 31, 2019 | 4,758.00 |
| Dec 31, 2018 | 3,961.00 |